BioFLO for Respiratory Recovery in SCI

NCT ID: NCT06011876

Last Updated: 2025-11-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-21

Study Completion Date

2027-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute intermittent hypoxia (AIH) involves brief (1 min), repeated episodes (\~15) of breathing low oxygen air to stimulate spinal neuroplasticity. Animal and human studies show that AIH improves motor function after spinal cord injury, particularly with slightly increased carbon dioxide (hypercapnic AIH; AIHH) and task-specific training. Using a double blind cross-over design, the study will test whether AIHH improves breathing more than AIH and whether specific genetic variations are related to individuals' intervention responses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will consist of two parts - single-session testing days, and respiratory strength training blocks. If a participant is not eligible to enroll in single-day testing, they will be asked to enroll in only the respiratory strength training blocks.

On single-session testing days, participants will be asked to come in on three separate days they will complete a battery of tests, then be given one of three interventions, and then complete the same battery of tests. The three interventions are acute intermittent hypoxia (AIH), acute intermittent hypercapnic-hypoxia (AIHH), or sham acute intermittent hypoxia (sham AIH). These interventions are explained in more detail below.

During respiratory strength training blocks, participants will receive five days of AIH, AIHH, or sham AIH in combination with respiratory strength training, which uses small hand-held devices to strengthen the muscles used for breathing. Participants will be asked to complete all three blocks to receive all three interventions. In addition to 5 days of interventions and respiratory strength training, the respiratory strength training blocks include testing 1 day, 3 days, and 7 days after the 5 days of respiratory strength training.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Cord Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single-session testing days

Participants will complete three separate single-session testing days. Baseline testing will be performed, then on each day, participants will receive AIH, AIHH, and sham AIH in random order. Post-testing will occur after each intervention.

Group Type EXPERIMENTAL

Acute Intermittent Hypoxia (AIH)

Intervention Type OTHER

AIH (acute intermittent hypoxia) consists of short episodes of low oxygen (9% O2).

Acute Intermittent Hypercapnic-Hypoxia (AIHH)

Intervention Type OTHER

AIHH consists of short episodes of low oxygen (9% O2) and elevated carbon dioxide (4% CO2).

Sham AIH

Intervention Type OTHER

A single session of sham AIH with episodes of normal room air (21% O2).

Respiratory strength training blocks

Participants will complete three separate respiratory strength training blocks. In each block, participants will receive 5 days of AIH, 5 days of AIHH, and 5 days of sham AIH in random order, followed by respiratory strength training. Each block will include 5 days of intervention and training, and post-testing 1, 3, and 7 days after intervention and training has concluded.

Group Type EXPERIMENTAL

Acute Intermittent Hypoxia (AIH)

Intervention Type OTHER

AIH (acute intermittent hypoxia) consists of short episodes of low oxygen (9% O2).

Acute Intermittent Hypercapnic-Hypoxia (AIHH)

Intervention Type OTHER

AIHH consists of short episodes of low oxygen (9% O2) and elevated carbon dioxide (4% CO2).

Sham AIH

Intervention Type OTHER

A single session of sham AIH with episodes of normal room air (21% O2).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acute Intermittent Hypoxia (AIH)

AIH (acute intermittent hypoxia) consists of short episodes of low oxygen (9% O2).

Intervention Type OTHER

Acute Intermittent Hypercapnic-Hypoxia (AIHH)

AIHH consists of short episodes of low oxygen (9% O2) and elevated carbon dioxide (4% CO2).

Intervention Type OTHER

Sham AIH

A single session of sham AIH with episodes of normal room air (21% O2).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adults 18-70 years of age
2. Chronic incomplete SCI ≥ 1 year at or below C1-T12

* Incomplete SCI based on residual sensory and motor function below the level of the injury or injury classification of B, C, D at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI.

-OR- Chronic complete SCI ≥1 year at or below C4-T12
* Complete SCI based on the absence of residual sensory or motor function below the level of injury or injury classification of A at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI.
3. Medically stable with physician clearance
4. SCI due to non-progressive etiology
5. 20% impairment in maximal inspiratory, maximal expiratory pressure generation, or both relative to normative values

Exclusion Criteria

1. Current diagnosis of an additional neurologic condition such as Multiple Sclerosis, Parkinson disease, stroke, or brain injury
2. Severe illness or infection, including non-healing decubitus ulcers, untreated bladder or urinary tract infections, cardiovascular disease, lung disease, active heterotopic ossification, or uncontrolled hypertension
3. Severe neuropathic pain
4. Known pregnancy
5. Severe recurrent autonomic dysreflexia

Exclusion for involvement in TMS - History of seizure disorder, uncontrolled migraines, presence of cardiac pacemaker, metal implants in skull, medications that lower seizure threshold.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

U.S. Army Medical Research Acquisition Activity

FED

Sponsor Role collaborator

University of Florida

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emily Fox, DPT, MHS, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Florida & Brooks Rehabilitation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brooks Rehabilitation

Jacksonville, Florida, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emily J Fox, PT, MHS, PhD

Role: CONTACT

904-742-2500

Hannah Snyder, M.S.

Role: CONTACT

904-345-6910

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Emily J. Fox, MHS, DPT, PhD

Role: primary

(904) 742-2500

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

W81XWH2210478

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

IRB202202891

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AIH-induced Walking Recovery After Subacute SCI
NCT02632422 ACTIVE_NOT_RECRUITING NA